REGENXBIO Announces Presentations at the Angiogenesis, Exudation, and Degeneration 2023 Conference
- Monday, February 6, 2023, 7:12
- PR Newswire
- Add a comment
ROCKVILLE, Md., Feb. 6, 2023 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced that three presentations on RGX-314 will be presented at the Angiogenesis, Exudation, and Degeneration 2023 Conference taking place virtually from February 10-11, 2023. New data will be presented…
About the Author
admin has written 20968 stories on this site.